MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

Wandercraft

Corporate markethumanoidCurated record
wandercraft.eu

Exoskeleton pioneer whose self-balancing bipedal control (from its Atalante X rehab exoskeleton and Eve personal exoskeleton) underpins Calvin-40, an AI-driven industrial humanoid for heavy load handling on assembly lines; Renault Group is its first commercial Calvin-40 customer and a Series D investor.

HeadquartersParis, FR
Founded2012
Corporate funding$146M
Team51-200
Deployments4
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries D
FoundersMatthieu Masselin, Nicolas Simon, Alexandre Boulanger, Jean-Louis Constanza
Regions servedEU, US
Countries deployedFR
Service footprintHQ Paris FR; US office in New York; Atalante X deployed in 100+ hospitals and rehabilitation centers across 15+ countries
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinehumanoid

Atalante X

  • Self-balancing medical exoskeleton for hospital rehabilitation training, FDA-cleared with extended indications

    vendor-defined clinical rehabilitation exoskeleton

    Claim source
Machinehumanoid

Calvin-40

  • Can lift up to ~40 kg (90 lb) several hundred times a day without rest

    vendor-claimed repeated lift payload and duty cycle

    Claim source
  • Designed for continuous use of 8 to 22 hours per day with a target fail rate < 1/1000

    vendor-defined operational duty cycle and reliability target

    Claim source
Machinehumanoid

Eve

  • First self-balancing personal exoskeleton, hands-free and usable without crutches (US clinical trial enrollment underway)

    vendor-defined personal mobility exoskeleton

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-06-25National Seating & Mobility (NSM)CRT distribution partner / Eve exoskeleton launchUSNot disclosedAnnouncement
2025-11-25Sapaindustrial manufacturingFRNot disclosedAnnouncement
2025-07-09Moody Neurorehabilitation InstituteneurorehabilitationUSNot disclosedAnnouncement
2025-06-06Renault Groupautomotive assembly plant (Douai)FRNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordRenault GroupBpifranceQuadrant ManagementTeampact VenturesLBO France
TL

Company timeline

Milestones and announcements

2026-03-10Renault announces plan to deploy 350 Calvin-40 humanoids across manufacturing facilities within 18 months; Douai plant already operational on tire handling tasksHumanoids Daily
2025-11-03FDA grants second indication extension for Atalante X covering high-level SCI (C4–L5) and multiple sclerosis; deployed 100+ rehab centers, 1M+ steps/monthGlobeNewswire
2025-06-11Raised $75M Series D led by Renault Group and Bpifrance for global Calvin-40 and Eve expansionWandercraft
2024-02-13Atalante X receives second FDA clearance for spinal cord injury rehabilitation (T5–L5)GlobeNewswire
2023-01-23Atalante X receives first FDA clearance (stroke/CVA rehabilitation)Newswire
2022-01-19Raised $45M Series C led by Quadrant Management for US expansion and Eve personal exoskeleton developmentTechCrunch
SC

Source ledger

19 unique public sources

01
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered roboticsGlobeNewswire / Wandercraft · retrieved 2026-07-05
02
French robotic exoskeleton maker Wandercraft eyes US expansion with $45M Series CTechCrunch · retrieved 2026-07-05
03
EU project: Memory of MotionCORDIS (European Commission) · retrieved 2026-07-05
04
XAnge, Idinvest et al. in €15m Wandercraft Series B (€15M EUR converted at ~1.19 EUR/USD)Unquote · retrieved 2026-07-05
05
Wandercraft et son exosquelette franchissent un pas avec une levée de 4 millions d'eurosMaddyness · retrieved 2026-07-05
06
Atalante X Rehabilitation ExoskeletonWandercraft · retrieved 2026-07-05
07
Wandercraft unveils Calvin, new industrial humanoid, and Renault partnershipThe Robot Report · retrieved 2026-07-05
08
Calvin-40 Industrial HumanoidWandercraft · retrieved 2026-07-05
09
Wandercraft - AI-powered roboticsWandercraft · retrieved 2026-07-05
10
Wandercraft Names National Seating & Mobility the Exclusive CRT Distribution Partner for Eve Personal ExoskeletonGlobeNewswire · retrieved 2026-07-05
11
Wandercraft and SAPA Announce Deployment Partnership to Implement and Scale Deployment of Calvin-40Humanoid Robotics Technology · retrieved 2026-07-05
12
Moody Neurorehabilitation Institute Acquires Wandercraft's Atalante X to Transform Care for Complex PatientsWandercraft · retrieved 2026-07-05
13
Renault Group finalises a strategic partnership with WandercraftRenault Group · retrieved 2026-07-05
14
· retrieved 2026-07-05
15
Renault to Deploy 350 Wandercraft Calvin Humanoids in Industrial Speed RunHumanoids Daily · retrieved 2026-07-05
16
Wandercraft Gains Second FDA Indication Extension for Atalante XGlobeNewswire · retrieved 2026-07-05
17
Wandercraft announces Series D RoundWandercraft · retrieved 2026-07-05
18
Wandercraft's exoskeleton receives second FDA clearance for spinal cord injury rehabilitationGlobeNewswire · retrieved 2026-07-05
19
Wandercraft Receives FDA Clearance for AtalanteNewswire · retrieved 2026-07-05